Previous Article | Next Article 
Infect Immun, January 1998, p. 161-168, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Distinct Characteristics of Resistance to
Borrelia burgdorferi-Induced Arthritis in C57BL/6N
Mice
Ying
Ma,1
Kathleen Petri
Seiler,1,
Ernst J.
Eichwald,1
John H.
Weis,1
Cory
Teuscher,2 and
Janis
J.
Weis1,*
Department of Pathology, University of Utah
School of Medicine, Salt Lake City, Utah,1
and
Department of Veterinary Pathobiology, University of
Illinois at Urbana-Champaign, Urbana, Illinois2
Received 17 July 1997/Returned for modification 4 September
1997/Accepted 28 October 1997
 |
ABSTRACT |
Studies of mice infected with Borrelia burgdorferi have
indicated that the severity of arthritis is influenced by the genetic composition of the host: the C3H mouse develops severe arthritis while
BALB/c and C57BL/6 mice develop mild arthritis. In this study, the
effects of increasing infectious dose on the severity of arthritis were
determined in these three mouse strains. C3H/He mice developed severe
arthritis at all infectious doses, with 100% infection requiring 200 spirochetes. In BALB/cAnN mice, arthritis severity was dependent on
infectious dose; symptoms were mild with infection by 200 B. burgdorferi and progressively more severe with increasing
infectious dose. Infection of BALB/cAnN mice with 2 × 104 B. burgdorferi resulted in arthritis
with severity identical to that in C3H/He mice. Spirochete levels in
rear ankle joints of C3H/HeJ and C3H/HeN mice were relatively high, as
detected by PCR, and did not increase with infectious dose. Spirochete levels in joints from BALB/cAnN mice increased with increasing infectious dose to levels found in severely arthritic C3H/He mice. Thus, resistance to severe arthritis in BALB/cAnN mice was conditional: it could be overcome by high infectious dose and the arthritis became
severe when high levels of B. burgdorferi were present in joints. A unique response to increasing infectious dose was seen in
C57BL/6N mice, which displayed mild to moderate arthritis at all doses
of B. burgdorferi tested, up to 2 × 105. At all infectious doses, the levels of spirochetes in
ankle joints of C57BL/6N mice were high, equivalent to those found in the severely arthritic C3H/He mice. The arthritis observed in infected
(C57BL/6N × C3H/HeN)F1 mice was of severity
intermediate between those of the two parental strains. The finding
that resistance to severe arthritis in C57BL/6N mice could not be
overcome by high infectious doses and was independent of spirochete
levels in joints suggested that it was mediated by a distinct mechanism from that operating in BALB/cAnN mice.
 |
INTRODUCTION |
Lyme disease is caused by infection
with the tick-transmitted spirochete Borrelia burgdorferi
and is characterized by multisystem involvement (14, 16,
24). Many tissues may display disease involvement, and there is
variability in the degree to which patients are affected. This
variability could be due to host, microbial, or environmental factors.
In fact, infection in Europe by related members of the B. burgdorferi sensu lato group is more frequently associated with
chronic skin abnormalities and central nervous system involvement,
while infection by B. burgdorferi sensu stricto in the
United States is more commonly associated with arthritis (4,
38). Studies using the murine model of Lyme disease, developed by
Barthold and colleagues, indicate host factors also influence disease
outcome. Arthritis seen in this model is representative of human
disease and is characterized by tendonitis, synovial hyperproliferation, and infiltration of neutrophils and other leukocytes (7). Interestingly, a spectrum of arthritis
severity has been observed among inbred strains of mice in response to infection by B. burgdorferi. Infected C3H mice develop
severe arthritis, whereas infected BALB/c and C57BL/6 mice develop only mild to moderate arthritis (8). Thus, inbred strains of mice provide opportunities to study host influences on disease severity.
The results of several studies using the mouse model suggest the
presence of inflammatory and/or anti-inflammatory cytokines can
influence disease development and resolution. For example, manipulations of interleukin 12, interleukin 4, and gamma interferon levels by treating infected mice with neutralizing antibodies can
influence disease severity and alter its resolution (2, 17,
21). The acquired defenses, particularly antibody production, are
clearly involved in disease resolution (9, 30) but do not
appear to be required for arthritis and carditis development. Not only
does disease develop in scid mice, which lack mature T and B
lymphocytes, but the relative differences in severity of arthritis in
C3H/He and BALB/c mice is maintained in the presence of the
scid mutation (12). Finally, studies with
congenic mice expressing distinct major histocompatibility complex
haplotypes on resistant or susceptible backgrounds suggest that the
major histocompatibility complex itself had little influence on disease severity, but rather, that genes located at distinct chromosomal locations were important determinants of disease (41). These studies suggest that genes independent of acquired defenses play a
large role in determining severity of disease in infected mice.
In order to identify host genes that influence disease severity, the
phenotypes of severe and mild arthritis must be well characterized. We
previously compared B. burgdorferi levels in many
tissues of C3H/HeJ and BALB/cJ mice, at several times following infection (42). Quantitative PCR demonstrated that the
highest levels of spirochetes were found in the hearts and ankle joints at most time points. C3H/HeJ mice harbored 5- to 10-fold more B. burgdorferi in ankles and hearts than did BALB/cJ
mice. This suggested that the severity of arthritis in C3H/HeJ mice was
directly related to the high levels of spirochetes in tissues and that the relative resistance in BALB/cJ mice was associated with more restricted growth of the spirochetes.
In this study we report that there are at least two different
mechanisms for resistance to severe arthritis in mice. Resistance in
BALB/cAnN mice could be overcome by increasing the infectious dose of
B. burgdorferi and was associated with low levels of
spirochetes in tissues. In contrast, resistance to severe arthritis in
C57BL/6N mice was not overcome by increasing infectious dose and did
not require the levels of spirochetes in joints to be low.
F1 mice from BALB/cAnN × C3H/HeJN mating developed
severe arthritis upon infection, suggesting that resistance in
BALB/cAnN mice could be masked by alleles from C3H/HeN mice
(42). In contrast, infection of F1 mice from a
C57BL/6N × C3H/HeN cross resulted in arthritis of intermediate
severity, suggesting more equal contribution by C57BL/6N and C3H/HeN
genes.
 |
MATERIALS AND METHODS |
Bacteria.
The N40 isolate of B. burgdorferi
was provided by Stephen Barthold (University of California at Davis) at
passage 3 from an infected mouse (8). Passage 4 cultures
were maintained as 0.5-ml frozen stocks at
70°C. HB-19 was provided
by Alan Barbour (University of California at Irvine) from an infectious
clone derived from the original human isolate (5). Fresh
aliquots of frozen stocks were seeded in 15 ml of BSK-H medium
containing 6% rabbit serum (Sigma, St. Louis, Mo.) and cultured at
32°C for 3 to 5 days prior to injection.
Mice.
Female C3H/HeJNCr, C3H/HeNCr, BALB/cAnNCr, C57BL/6NCr,
and B6C3F1 (C57BL/6NCr × C3H/HeNCr) mice were
obtained from the National Cancer Institute at 5 weeks of age. During
the course of these studies we observed that substrain differences in
C57BL/6 mice could influence the degree of arthritis severity. Mice
were housed in the Animal Resource Center at the University of Utah
Medical Center, according to guidelines of the National Institutes of Health for the care and use of laboratory animals.
Infection of mice with B. burgdorferi.
Mice 5 to
6 weeks of age were infected by intradermal injection with the
indicated number of B. burgdorferi in the shaven back,
a mode of infection reported to require the fewest spirochetes and to
most closely mimic tick transmission (6, 25). Spirochete concentrations of 3- to 5-day cultures were determined by darkfield microscopy with a Petroff-Hauser chamber. Dilutions were made with
sterile culture medium to allow injection of 20 µl per animal. Control mice were injected with an equal volume of sterile medium.
Measurement of the ankle joints.
Rear ankle joints of mice
anesthetized with methoxyflurane (Pitman-Moore) were measured with a
metric caliper (Dolla Eastern, Long Island City, N.Y.). Ankle joint
measurements have been previously shown to correlate with the
histological severity of arthritis and provide a method of monitoring
arthritis development without sacrificing the animal (41).
Measurements were taken in the anterior and/or posterior position with
the ankle extended, which was through the thickest portion of the
ankle. Normal ankle joints have a diameter of approximately 3 mm at
this position.
Histology of the ankle joints.
The rear ankle joint
displaying the greatest swelling at the 4-week sacrifice was taken from
each mouse for histological analysis. Samples were fixed in 10%
formalin, decalcified, and embedded in paraffin, and sections were
stained with hematoxylin and eosin. Slides were viewed in a blinded
fashion and given a score for severity. A score of 4+ indicated the
greatest severity in tissues of the ankle and tibia and was
characterized by a large region of edema with the presence of many
neutrophils, thickening of the tendon sheath, and evidence of bone and
cartilage abnormalities within the tendon sheath. A score of 1+
displayed slight thickening of the tendon sheath and little edema and
neutrophil infiltration, whereas a score of 0 was given to samples
indistinguishable from mock-infected controls. Scores of 2 and 3 were
assigned to samples with intermediate pathologies.
Preparation of DNA from infected tissues.
Control and
infected mice were sacrificed at 4 weeks following infection, and rear
ankle joint tissues and hearts were prepared as previously described
(32). Tissues were placed individually in 15-ml
polypropylene tubes containing 2.5 ml of a 0.1% collagenase A
(Boehringer Mannheim) solution in phosphate-buffered saline (pH 7.4).
Samples were digested with collagenase for 4 h at 37°C and then
mixed with an equal volume of 0.2-mg/ml proteinase K (Boehringer
Mannheim) in 200 mM NaCl-20 mM Tris-HCl (pH 8.0)-50 mM EDTA-1%
sodium dodecyl sulfate for 16 h at 55°C. DNA was recovered by
extraction with an equal volume of phenol:chloroform and precipitation with ethanol. Following digestion with 1-mg/ml DNase-free RNase (Sigma), the DNA samples were subjected to a second extraction and
precipitation and finally resuspended in 1.5 ml of distilled water. The
average recovery was 200 to 400 µg of DNA from each heart and ankle,
as determined by absorbance at 260 nm.
Detection of B. burgdorferi sequences by
PCR.
PCR amplification was performed essentially as described
previously by using the 1605 Air Thermocycler (Idaho Technologies) (42). Amplification was performed with 150 ng of DNA in a
10-µl final volume containing reaction buffer (50 mM Tris [pH 8.3], 3 mM MgCl2, 20 mM KCl, and 0.5 mg of bovine serum albumin
per ml), 70 pmol of each oligonucleotide, 0.2 mM deoxynucleoside
triphosphates (GIBCO BRL), 2.5 µCi of [32P]dCTP (New
England Nuclear Research Product), and 0.75 U of Taq DNA
polymerase (5,000 U/ml; BRL-GIBCO) (37). The oligonucleotide primers used to detect ospA were ospA 149 (5'-TTA
TGA AAA AAT ATT TAT TGG GAA T-3') and ospA 319 (5'-CTT TAA
GCT CAA GCT TGT CTA CTG T-3') (23). The primers used to
detect ospB were ospB 219 (5'-CTC CGG CAA ATA TGA
TTT AAG AGC A-3') and ospB 1411 (5'-AGC TTT GAG AGT TTC CTC
TGT TAT TGA-3') (23). In some experiments ospB
146 (5'-TTC CTG CGG TGA CAG AAG AC-3') was substituted for ospB 219, allowing amplification of a larger region of the
ospB gene. The primers for nidogen were 5'-CCA GCC ACA GAA
TAC CAT CC-3' and 5'-GGA CAT ACT CTG CTG CCA TC-3' (42).
Reaction conditions for the 195-bp product from ospA were 35 cycles of denaturing at 94°C for 1 s, annealing at 55°C for
1 s, and elongation at 72°C for 12 s. Reaction conditions
for the 238-bp ospB 219-ospB-1411 product were 30 to 31 cycles of denaturing at 94°C for 1 s, annealing at 65°C
for 1 s, and elongation at 72°C for 8 s. Reaction
conditions for the 311-bp ospB 146-ospB-1411
product were 33 cycles of denaturing at 94°C for 1 s, annealing
at 68°C for 1 s, and elongation at 72°C for 8 s. Reaction
conditions for the 150-bp nidogen product were 20 to 22 cycles of
denaturing at 94°C for 1 s, annealing at 60°C for 1 s,
and elongation at 72°C for 6 s. Cycle number variations for some
products are due to slight differences in the ages of the
radionucleotides.
Reaction products were separated on a 6% polyacrylamide sequencing
gel. Products were identified by autoradiography and, in experiments
shown in Fig. 3, were quantified by densitometric scanning with a
Bio-Rad molecular imager. Once phosphor image analysis became readily
available, gels were subjected to phosphor image analysis for
quantitation of products by using a Bio-Rad molecular imager. DNA from
each group of animals was amplified with nidogen primers and analyzed
on a single gel. Samples were adjusted to fall within a twofold range
for nidogen product, which was confirmed by analysis of a second set of
reactions. This ensured approximately equal loading of tissue DNA for
detection of B. burgdorferi product. Amplification of
B. burgdorferi sequences was performed with
ospA or ospB primers at cycle numbers within the
linear range for product. As demonstrated previously, product yields
were a direct reflection of the relative amounts of B. burgdorferi in tissues (42). DNA from mock-infected
mice was included in each set of reactions to control for reagent and
DNA purity. pBR332 DNA which had been digested with MspI and
endlabeled with [32P]dCTP was used as a molecular weight
ladder for the gels.
Standard curve for B. burgdorferi DNA.
A
standard curve for detection of B. burgdorferi DNA in
mouse tissue was generated by spiking a constant number of freshly isolated mouse splenocytes with increasing numbers of B. burgdorferi. The ability to detect B. burgdorferi
sequences in these spiked mouse tissues was determined by PCR, which
indicated that this technique provides efficient recovery of
B. burgdorferi DNA in the presence of mouse tissues.
The nidogen contents of standard curve samples were equilibrated with
those used for ankles and joints and then amplified with primers for
ospB. The quantity of product was determined by phosphor
image analysis and was found to be linear for standards in the range of
6 to 690 B. burgdorferi equivalents per amplification
reaction. Comparison of product from tissue samples with the standard
curve allowed estimation of the quantity of B. burgdorferi DNA sequences present in infected mouse tissues.
Quantification of B. burgdorferi-specific IgM
and IgG.
Serum samples from infected and control mice were taken
from each mouse at the 4-week sacrifice and analyzed for B. burgdorferi-specific antibody by a quantitative enzyme-linked
immunosorbent assay described previously (32). Sera from
uninfected mice had B. burgdorferi-specific immunoglobulin G (IgG) levels less than 100 ng/ml, whereas sera from
infected mice had specific IgG levels greater than 20 µg/ml. By this
criterion, all animals injected with greater than 200 B. burgdorferi were infected. Further, B. burgdorferi-specific PCR products were only detected in tissues
from mice positive for B. burgdorferi-specific
antibody.
Statistical analysis.
The degree of statistical significance
of the quantitative differences between sample groups was determined by
application of Student's t test.
 |
RESULTS |
Effects of B. burgdorferi inoculum on arthritis
development in BALB/cAnN and C3H/HeJN mice.
Our initial studies
comparing mildly arthritic and severely arthritic mice infected with
B. burgdorferi focused on two strains of inbred mice:
C3H/He and BALB/c (32, 41, 42). C3H/He mice develop severe
arthritis 3 to 4 weeks following intradermal injection of
spirochetes, whereas BALB/c mice infected with the same isolate of
B. burgdorferi develop mild arthritis. We
observed a sudden increase in virulence of the N40 isolate of
B. burgdorferi maintained in our laboratory that
occurred following a change in growth medium to the commercially
prepared BSK-H. This was characterized by a 50-fold decrease in the
number of B. burgdorferi required for 50% infection (a
reduction from 1,000 spirochetes to 20 spirochetes) and by an increase
in severity of disease. This was most obvious in BALB/c mice, which
developed severe arthritis when infected with 2 × 105
spirochetes, a dose which previously was consistently associated with
mild arthritis (41, 42). For all three strains of inbred mice used in this study infection rates of 25 to 75% were obtained in
groups inoculated with 20 spirochetes, while 100% infection was found
in mice receiving 200 B. burgdorferi, similar to
reports of others (6).
We investigated the effects of increasing the inoculum of B. burgdorferi from 20 to 2 × 104 on the
development of arthritis in BALB/cAnN and C3H/HeJN mice. Groups of
three to four mice were injected with each dose of B. burgdorferi, and rear ankle measurements were taken at weekly intervals from each mouse to monitor disease progression (Fig. 1). As not all mice injected with 20 spirochetes became infected, they were not included in further
analysis. All C3H/HeJN mice injected with 200 spirochetes became
infected, as determined by ankle swelling, PCR detection of
B. burgdorferi DNA in tissues, and enzyme-linked
immunosorbent assay detection of elevated anti-B. burgdorferi IgG in serum (described in Materials and Methods). BALB/cAnN mice injected with 200 B. burgdorferi did not
display ankle measurements greater than those of mock-infected control mice but did have elevated IgG levels and detectable B. burgdorferi DNA, indicative of infection. BALB/cAnN mice infected
with 2 × 103 or 2 × 104
B. burgdorferi developed progressively increasing ankle
swelling. The mice which were used to obtain the results shown in Fig.
1 were sacrificed at 4 weeks following infection, and the most severely swollen rear ankle from each mouse was taken for histological analysis.
The remaining rear ankle of each mouse was used for preparation of DNA.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Effects of increasing infectious dose on B. burgdorferi-induced ankle swelling in BALB/cAnN and C3H/HeJN mice.
Groups of three to four C3H/HeJN (circles) or BALB/cAnN (squares) mice
were infected by intradermal injection with the indicated numbers of
the N40 strain of B. burgdorferi (filled symbols).
Uninfected control mice were injected with sterile medium (open
symbols). Measurements of the most severely swollen ankle were
collected weekly for each animal, and the data shown are average values
at each time point for each treatment group. Error bars indicate
standard deviations within the groups. The same group of mock-infected
mice is shown in each panel for comparison. Mice were sacrificed at 4 weeks postinfection and used for the analyses shown in Fig. 2 and 3.
|
|
The caliper measurements of ankle swelling are reflective of the amount
of edema associated with the region directly proximal to the ankle and
provide a gross measurement of the inflammatory response. A more
complete determination of arthritis severity is revealed by
histological analysis. Figure 2 shows
hematoxylin-and-eosin-stained slides prepared from BALB/cAnN mice
representative of the groups infected with 2 × 104
B. burgdorferi shown in Fig. 1. The histological
abnormalities of joints from BALB/cAnN mice infected with 2 × 104 B. burgdorferi were severe and similar
to those seen with C3H/He mice (7) (see also Fig. 5C).
Severe arthritis was characterized by tendonitis and hyperproliferation
of the tendon sheath (Fig. 2). Neutrophils were abundant in the
inflammatory infiltrate, along with a prevalence of mononuclear cells,
plasma cells, and mast cells. Figure 2B, from a BALB/cAnN mouse, shows
another abnormal feature commonly seen in severe B. burgdorferi-induced arthritis in C3H mice: a conspicuous area of
chondrocyte development, adjacent to a region of newly formed bone
within the tendon sheath of the tibiotarsal region (42).
Histological assessment of rear ankle joints from the BALB/cAnN mice
revealed an increase in severity associated with increasing infectious
dose, with mice inoculated with 200 B. burgdorferi
receiving a histopathological score of 1 ± 0.5, those inoculated
with 2 × 103 B. burgdorferi receiving
a score of 1 ± 0.82, and those inoculated with 2 × 104 B. burgdorferi receiving a score of
3.75 ± 0.5. The average score for C3H/HeJ mice was 3.08 ± 0.79. The findings of a dose-dependent increase in arthritis severity
in BALB/cAnN mice have been repeated in a second experiment with
the N40 isolate and have also been found with a second
B. burgdorferi isolate, HB19 (data not shown).

View larger version (165K):
[in this window]
[in a new window]
|
FIG. 2.
Histological analysis of severely arthritic BALB/cAnN
mice. (A) Hematoxylin-and-eosin-stained slide from a representative
BALB/cAnN mouse from Fig. 1 infected with 2 × 104
B. burgdorferi. Note the thickening of the tendon
sheath in the region of the ankle joint. Magnification, ×5.75. (B)
Area within the tendon sheath displaying abnormalities of chondrocyte
and bone proliferation (arrow). Magnification, ×11.5. For comparison,
severe arthritis in C3H/He mice can be seen in Fig. 5C.
|
|
Effects of increasing inoculum on spirochete presence in BALB/cAnN
and C3H/HeJN mice.
We previously reported that mildly arthritic
BALB/cJ mice possessed 5- to 10-fold fewer spirochetes in joint tissues
and hearts than did those tissues from severely arthritic C3H/HeJ mice
(42). This was determined for a large number of samples by
using the semi-quantitative PCR technique also used in this study and
was confirmed for representative samples by a truly
quantitative competitive target procedure. For the experiment
whose results are shown in Fig. 1, we wished to determine whether the
increase in severity of arthritis in BALB/cAnN mice receiving high
doses of spirochetes was correlated with increased numbers of
spirochetes in infected tissues. For each mouse included in this study,
DNA was isolated from tissue taken from the rear ankle joint not
collected for histology and subjected to semi-quantitative PCR for
detection of B. burgdorferi sequences. Data in Fig.
3 indicate that increasing the infectious
dose of B. burgdorferi given to C3H/HeJN mice had only
a minor effect on the level of B. burgdorferi DNA in
rear ankle joint tissue. In contrast, infected BALB/cAnN mice displayed a trend associating increasing dose with increasing amounts of B. burgdorferi DNA in joints. BALB/cAnN mice inoculated
with 200 B. burgdorferi had significantly less
B. burgdorferi DNA in ankle tissues than did C3H mice
(P = 0.015). This difference was less significant in
BALB/cAnN infected with 2,000 B. burgdorferi
(P = 0.067). BALB/cAnN mice inoculated with the highest
dose of B. burgdorferi (2 × 104) had
levels of spirochetes in joints similar to those found in severely
arthritic C3H/HeJN mice (P = 0.46). These results
indicate that doses of B. burgdorferi that overcome
resistance to arthritis in BALB/cAnN mice are correlated with the
presence of high numbers of spirochetes in joint tissues.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Detection of spirochete DNA in tissues of mice infected
with increasing concentrations of B. burgdorferi. DNA
from the mice from Fig. 1 was prepared at sacrifice, and
semiquantitative PCR was used to assess the quantity of B. burgdorferi persisting in the rear ankle joint. Samples were
amplified with primers for nidogen to ensure loading equivalence and
with ospA primers to detect B. burgdorferi
DNA, as described in Materials and Methods. The relative intensities of
bands were determined by densitometric scanning. Relative densitometric
units were determined for ospA products from each infected
mouse (three to four mice per group) and are indicated by the open
circles while the bold bars indicate the averages for each group. The
means and standard deviations for the relative band intensities at the
2 × 102 infection dose were 2.0 ± 1.8 and
13.3 ± 9.6 for the BALB/c and C3H/HeJN mice, respectively. The
corresponding results for the other doses were 4.1 ± 4.9 and
15.3 ± 6.6 (2 × 103) and 18.9 ± 12.5 and
16.48 ± 8.9 (2 × 104) for the BALB/c and
C3H/HeJN mice, respectively.
|
|
Effects of B. burgdorferi dose on arthritis
development in C57BL/6N and C3H/HeN mice.
The effect of increasing
infectious dose was also tested in C57BL/6N mice, which have been
reported to develop mild arthritis when infected with B. burgdorferi (8, 10). Since we wished to assess
arthritis severity in F1 mice, C3H/HeN mice were used as
positive controls for arthritis development rather than C3H/HeJN mice
because the B6C3F1 mice (C3H/HeN × C57BL/6N) were
available from the vendor only with the C3H/HeN parent. The
endotoxin hyporesponsive mutation of the C3H/HeJ mouse has been
shown to have no effect on any measurable parameter of B. burgdorferi-induced disease (11, 42). The degree of
arthritis development in groups of four to five mice infected with
doses of B. burgdorferi ranging from 200 to 2 × 105 was monitored by weekly ankle measurements (Fig.
4A). The degree of ankle swelling was
high in C3H/HeN mice at all infectious doses. C57BL/6N mice were
resistant to severe arthritis even at the highest infectious dose,
2 × 105. Grouped by the degree of rear ankle
swelling, C3H/HeN and C57BL/6N mice formed two
nonoverlapping groups at each time point and each infectious
dose.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of infectious dose on ankle swelling in C57BL/6N
and C3H/HeN mice. (A) Groups of four to five C57BL/6N (squares) and
C3H/HeN (circles) mice were infected by intradermal injection with the
indicated numbers of the N40 strain of B. burgdorferi
(filled symbols). Uninfected control mice were injected with sterile
medium (open symbols). Weekly measurements of the most severely swollen
ankle were made for each animal, and the values were used to determine
the means and standard deviations (error bars) within each treatment
group at each time point. The same mock-infected mice from each mouse
strain are included in each panel for comparison. Mice were sacrificed
at 4 weeks postinfection and were used for the analyses shown in Fig. 5
to 7. (B) B6C3F1 mice (triangles) were infected at the same
time and with the same doses as the parental mice shown in panel A. Rear ankle measurements from infected B6C3F1 (triangles)
are shown in comparison with infected parental strains (same symbols as
for panel A). Measurements for uninfected B6C3F1 mice were
similar to those for parental mice shown in panel A.
|
|
The rear ankle joint displaying the highest degree of swelling in
each mouse was assessed for histopathology. There was much less
inflammatory involvement in C57BL/6N than in C3H/HeN mice (Fig.
5). Most joints from C57BL/6N mice had
little synovial hyperproliferation or tendonitis, even those from mice
inoculated with 2 × 105 B. burgdorferi. A range of arthritis severity was observed in C57BL/6N at each inoculum dose, with one or two mice developing moderate synovial hyperproliferation (1+ to 2+) and the remaining three
or four displaying very limited abnormality (0 to 1+). The average
histopathological score for all C57BL/6N mice shown in Fig. 4 was
0.78 ± 0.79, for C3H/HeN mice it was 3.58 ± 0.49, and for
the B6C3F1 mice it was 1.53 ± 0.75. In a second
experiment, in which arthritis severity in C57BL/6N mice was compared
with that in C3H/HeJN mice, similar results to those shown in Fig. 4
and 5 were obtained (data not shown).

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 5.
Histological analysis of tendonitis development in
C57BL/6N, C3H/HeN, and B6C3F1 mice infected with 2 × 104 B. burgdorferi. (A) Representative
ankle joint from a C57BL/6N mouse from the experiment shown in Fig. 4.
There is very little edema or change in the tendon sheath evident in
this section. (B) Ankle joint from a representative B6C3F1
mouse from Fig. 4 showing evidence of arthritis. Note the presence of
edema surrounding the tendon crossing the ankle. (C) Ankle joint from a
representative C3H/HeN mouse from Fig. 4 showing evidence of severe
arthritis. Note the predominant thickening of the tendon sheath in the
tibiotarsal region. Arrows identify prominant tendons. Magnification,
×5.75.
|
|
Effects of inoculum size on B. burgdorferi
persistence in tissues of C57BL/6N and C3H/HeN mice.
Our
findings with BALB/c mice (42) (Fig. 3) suggested that
the mild pathology seen in C57BL/6N mice would be associated with lower
levels of spirochetes in the joint tissues than those in the severely
arthritic C3H/HeN mice. Semiquantitative PCR revealed that spirochete
levels did not increase with increasing infectious dose in either
C3H/HeN or C57BL/6N mice and that C57BL/6N mice harbored levels as
high as those found in C3H/HeN mice (Fig.
6). To demonstrate that relative
differences would have been detected by this protocol, a standard curve
spanning the range of B. burgdorferi DNA detected in
tissue samples was included with each set of reaction. This allowed
normalization of samples run on separate gels and allowed estimation of
actual B. burgdorferi numbers in infected ankle joints.
Because results from several individual gels were pooled, the data
presented in Fig. 6 are expressed as spirochete numbers rather than as
relative band intensities. At all B. burgdorferi doses,
rear ankle joint tissue from C3H/HeN and C57BL/6N mice possessed
approximately equal amounts of spirochete DNA. (The P values
for the comparisons of the various doses were as follows: infectious
dose at 200 B. burgdorferi, P = 0.98;
dose of 2 × 103, P = 0.39; dose of
2 × 104, P = 0.13; dose of 2 × 105, P = 0.70; pooling of data from all
C57BL/6N and C3H/HeN mice, P = 0.25.) The standard
curve was linear for samples containing 6 to 690 B. burgdorferi in the preamplified reaction mixture and spanned the
range found in samples from infected tissues. This demonstrates that
the technique would have allowed the distinction of 5- to 10-fold
differences in spirochete numbers in the C57BL/6N and C3H/HeN samples,
as were previously observed with BALB/cJ mice and C3H/HeJ mice. The
estimated average number of spirochetes in C3H/HeN ankle joints
analyzed in Fig. 6 was 6.4 × 105, similar to our
previous estimate of 4.3 × 105 for C3H/HeJ mice,
which was also obtained by using this technique (42). PCR
analysis of tissues collected in the second dose-response experiment,
in which C57BL/6N mice were compared with C3H/HeJN mice, gave similar
results for spirochete levels in ankles (data not shown). These results
indicate that spirochete numbers in mildly arthritic joints of C57BL/6N
mice were as high as in joints from severely arthritic C3H/HeN mice.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 6.
Effects of B. burgdorferi infectious
dose on DNA levels in ankle joints from C57BL/6N and C3H/HeN mice. The
concentrations of DNA in the samples were adjusted based on products
generated with nidogen primers, as described in Materials and Methods.
Samples were amplified with primers for ospB, and products
were quantified by phosphor image analysis. The estimation of total
B. burgdorferi numbers in each sample of joint DNA was
made by comparison with a standard curve, generated as described in
Materials and Methods, and calculated from the fraction of total DNA
amplified in the PCR. Open circles indicate spirochete numbers from
each mouse, and bold bars indicate average numbers for the groups of 4 to 5 mice. Spirochete numbers (means ± standard deviations) per
tissue are given for each infectious dose with group A receiving 2 × 102 (C57BL/6, [7.7 ± 10.6] × 105;
C3H/HeN, [7.9 ± 5.2] × 105), group B receiving
2 × 103 (C57BL/6, [4.3 ± 4.2] × 105; C3H/HeN, [6.3 ± 2.6] × 105),
group C receiving 2 × 104 (C57BL/6, [2.3 ± 2.9] × 105; C3H/HeN, [6.9 ± 5.4] × 105), and group D receiving 2 × 105
B. burgdorferi (C57BL/6, [3.9 ± 4.0] × 105; C3H/HeN, [4.8 ± 2.9] × 105).
|
|
The heart is a second tissue which is heavily infected with
B. burgdorferi in the mouse, and cardiac involvement
has been demonstrated in C3H/He, BALB/c, and C57BL/6 mice (8, 12, 29). We previously reported that infected C3H/HeJ mice possessed higher levels of B. burgdorferi DNA in hearts than did
BALB/cJ mice, at several time points following infection
(42). Levels of spirochete-specific DNA in hearts of the
BALB/cAnN mice shown in Fig. 1 did increase with increasing infectious
dose of B. burgdorferi, with hearts from BALB/cAnN mice
infected with 2 × 104 B. burgdorferi
having levels equivalent to those in C3H/HeJN mice (data not shown but
the trends were very similar to those shown for ankles in Fig. 3). PCR
amplification was also performed on DNA prepared from the hearts of the
C3H/HeN and C57BL/6N mice shown in Fig. 4. Increased inoculating dose
did not cause an increase in the numbers of spirochetes in hearts from
either C3H/HeN or C57BL/6N mice (data not shown), consistent with the
findings with the ankle joints from these mice, shown in Fig. 6.
However, direct comparison of the PCR products generated from heart
samples of C57BL/6N and C3H/HeN mice at each infectious dose of
B. burgdorferi revealed significantly higher spirochete
levels in C3H/HeN mice than in C57BL/6N mice (P < 0.05) (Fig. 7).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 7.
Detection of B. burgdorferi DNA in
hearts collected from infected C3H/HeN, C57BL/6N, and
B6C3F1 mice. Hearts were collected from the mice in Fig. 4,
and DNA was prepared for PCR analysis. Samples were determined to
contain equivalent amounts of DNA by amplification with nidogen
primers, as described in Materials and Methods. Samples for mice
infected with each indicated dose of B. burgdorferi
were amplified with ospB primers. Phosphor image
determination of relative quantities of product were made from samples
run on a single gel. Open circles indicate relative band intensities
from individual mice and bold bars reflect averages for the groups of 4 to 5 mice. Although means and standard deviations cannot be compared
between samples run on different gels, comparisons between C3H/HeN and
C57BL/6N mice at each dose of B. burgdorferi were made
and indicated significant differences as follows: dose of 200, P = 0.007; dose of 2 × 103,
P = 0.032; dose of 2 × 104,
P = 0.001; dose of 2 × 105,
P = 0.002.
|
|
Assessment of arthritis severity and spirochete persistence in
B6C3F1 mice.
We previously reported that the (C3H/HeJ × BALB/cJ)F1 mouse developed severe arthritis following
infection with the N40 strain of B. burgdorferi and
harbored high levels of spirochetes in tissues (42). This
result has been confirmed in (C3H/HeJN × BALB/cAnN)F1 mice, with an inoculating dose of 200 spirochetes of the highly virulent N40 cultures used in the present study (data not shown). The
severity of arthritis and the prevalence of spirochetes in tissues was
assessed in the F1 generation of a cross between C3H/HeN and C57BL/6N mice (B6C3F1). As shown in Fig. 4B,
B6C3F1 mice develop rear ankle swelling intermediate to
that observed in the parental strains at all infectious doses.
Histological analysis also reflected pathology that was intermediate to
that observed with C3H/HeN and C57BL/6N mice (Fig. 5). Spirochete
levels in rear ankle joint tissues taken at 4 weeks postinfection were
similar to those found in the two parental strains (data not shown).
Interestingly, spirochete levels in hearts were intermediate between
those of the two parental strains (Fig. 7). Unfortunately, the
relevance to carditis development could not be assessed in this
experiment, as all hearts were used for DNA preparation.
 |
DISCUSSION |
This study of arthritis development in mice infected with
increasing doses of B. burgdorferi suggests that
disease outcomes may be influenced at several stages. Resistance to
severe arthritis in BALB/cAnN mice is dependent on a low initial
infectious dose and appears to depend on the mouse's ability to
control the expansion of spirochetes within tissues. Infectious doses
of 2 × 104 and higher result in severe ankle swelling
and rear ankle arthritis in BALB/cAnN mice. Severe arthritis in the
BALB/cAnN mouse is associated with higher levels of spirochetes in
ankle joints. In contrast, the C57BL/6N mouse is resistant to severe
arthritis development even at very high infectious doses of
B. burgdorferi. Of particular interest is that the
mildly arthritic C57BL/6N mice harbor high levels of B. burgdorferi in tissues of the rear ankle joint. These findings
indicate that two distinct mechanisms can be responsible for arthritis
resistance. One, as seen in BALB/cAnN mice, is dependent on controlling
spirochete levels in tissues and can be overcome by high infectious
dose. The second, exemplified by the C57BL/6N mouse, is independent of
infectious dose and is not strictly tied to minimizing the presence of
spirochetes in tissues.
These studies imply that many aspects of host-pathogen interactions
contribute to the development of arthritis in B. burgdorferi-infected mice. Clearly, the bacterium is highly
invasive, and it has been shown by culture, silver staining,
immunochemistry, in situ hybridization, and PCR to be present in many
tissues including the joints (3, 11, 42). B. burgdorferi can transcytose endothelial monolayers in vitro,
suggesting direct mechanisms for tissue invasion (15, 36).
The spirochete expresses products of different lipoprotein genes at
different stages of infection of ticks and mammals (1, 18, 28, 31,
35, 39). The lipid-modified amino-terminal regions of these
lipoproteins are potent activators of mouse and human cells and are
capable of stimulating cytokine and nitric oxide production by
macrophages (19, 20, 27), adhesion molecule and chemokine
expression by endothelial cells (13, 33, 34, 40), and
adhesion molecule expression and release of granule contents by
neutrophils (22). Thus, the presence of lipoproteins in
infected tissues could participate in the inflammatory processes. The
comparison between BALB/cAnN and C57BL/6N mice is interesting in that
it suggests that BALB/cAnN mice are just as susceptible to severe
arthritis as are C3H/HeJN mice but that they are better at controlling
B. burgdorferi dissemination or growth. In contrast, the rear ankle joint tissues of C57BL/6N mice harbor as many
spirochetes as do C3H/HeN mice, yet arthritis severity is much less.
This suggests that the C57BL/6N mice are truly resistant to the
development of severe arthritis, even in the presence of the high
numbers of spirochetes and their inflammatory lipoproteins that are
associated with severe arthritis in C3H/HeN mice. Whether this reflects
greater regulation of inflammatory responses by infected C57BL/6N mice or alteration in inflammatory potential by B. burgdorferi infecting this host is not known.
The finding that C3H/HeN mice harbor higher levels of spirochetes in
hearts than do C57BL/6N mice suggests that there is variability in the
level of B. burgdorferi present in various tissues of
C57BL/6N mice. Thus, studies designed to test the influence of
manipulations of immune defenses on control of spirochetes may need to
sample more than one type of tissue. C3H mice are reported to have more severe carditis than C57BL/6 mice, suggesting that pathology in hearts
may be related to spirochete levels in this tissue (3, 8,
12). Demonstration that B. burgdorferi DNA levels
in the hearts of B6C3F1 mice are intermediate between those
of the two parental strains indicates that this trait is genetically
regulated and maintained over a wide range of infectious doses. Further experiments will be required to assess the effects of infectious dose
on carditis in C3H/HeN, C57BL/6N, and B6C3F1 mice. Others have reported a correlation between spirochete numbers and joint and
neurological pathology in scid mice infected with the
relapsing fever agent Borrelia turicatae, consistent with
our results with BALB/c and C3H mice (26).
Identification of a mouse strain which is highly resistant to
B. burgdorferi-induced severe arthritis will permit
elucidation of the genetic contribution to this process of infection.
The intermediate arthritis phenotype identified in the
B6C3F1 mice implies that homozygosity at a particular C3H
genetic allele(s) is required for development of the most severe
arthritis. This is in contrast to infection of the (BALB/c × C3H)F1 mice, which develop severe arthritis, and suggests
that the resistance of BALB/c mice can be more easily overcome by the
presence of a single C3H allele for a crucial gene(s) than can the
resistance of C57BL/6 mice. Important genes could include regulatory
molecules for inflammatory events, inflammatory genes themselves, and
genes that influence the emigration of leukocytes into tissues. Studies
of mice which express a granulocyte deficiency (beige) and
of mice treated with cytokine-neutralizing antibodies support the
suggestion that allelic differences in inflammatory pathways could
alter disease outcome (10, 17, 21). The finding that the
relative degree of severity of arthritis in BALB/c and C3H/HeN mice is
maintained in animals with the scid mutation (12)
further suggests that genes involved in innate host defenses may make
important contributions to severity phenotypes.
In summary, this study provides evidence that distinct mechanisms can
limit arthritis severity in mice. In a population of patients with Lyme
disease, there is observed a spectrum of disease severity and
differences in the organs that become involved (24). Some of
this variety is likely to reflect different abilities of patients to
effectively respond to B. burgdorferi infection. Additionally, the characteristics of the infecting pathogen and the
number of infecting bacteria may also influence pathological outcome.
Understanding host factors that influence resistance to arthritis in
mice infected with B. burgdorferi may have important implications for humans.
 |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grants AR43521
(to J.J.W. and C.T.) and AI24158 (to J.H.W.) from the National Institutes of Health and grant 5P30-CA-42014 to the University of Utah.
The project described was also supported in part by an award from the
American Lung Association (J.H.W.).
We acknowledge the help of Nancy Chandler in the University of Utah
Health Sciences Research Microscopy Facility and the helpful suggestions of Stephen Barthold, University of California at Davis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, University of Utah School of Medicine, 50 N. Medical Dr., Salt Lake City, UT 84132. Phone: (801) 581-8386. Fax: (801) 581-4517. E-mail: JanisWeis{at}hlthsci.med.utah.edu.
Present address: Pikeville College School of Osteopathic Medicine,
Pikeville, Ky.
Editor: J. R. McGhee
 |
REFERENCES |
| 1.
|
Akins, D. R.,
S. F. Porcella,
T. G. Popova,
D. Shevchenko,
S. I. Baker,
M. Li,
M. V. Norgard, and J. D. Radolf.
1995.
Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue.
Mol. Microbiol.
18:507-520[Medline].
|
| 2.
|
Anguita, J.,
D. H. Persing,
M. Rincon,
S. W. Barthold, and E. Fikrig.
1996.
Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
J. Clin. Invest.
97:1028-1034[Medline].
|
| 3.
|
Armstrong, A. L.,
S. W. Barthold,
D. H. Persing, and D. S. Beck.
1992.
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.
Am. J. Trop. Med. Hyg.
47:249-258.
|
| 4.
|
Balmelli, T., and J. C. Piffaretti.
1995.
Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato.
Res. Microbiol.
146:329-340[Medline].
|
| 5.
|
Barbour, A. G.,
S. L. Tessier, and W. J. Todd.
1983.
Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.
Infect. Immun.
41:795-804[Abstract/Free Full Text].
|
| 6.
|
Barthold, S. W.
1991.
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice.
J. Infect. Dis.
163:419-420[Medline].
|
| 7.
|
Barthold, S. W.
1996.
Lyme borreliosis in the laboratory mouse.
J. Spirochetal Tick-borne Dis.
3:22-44.
|
| 8.
|
Barthold, S. W.,
D. S. Beck,
G. M. Hansen,
G. A. Terwilliger, and K. D. Moody.
1990.
Lyme borreliosis in selected strains and ages of laboratory mice.
J. Infect. Dis.
162:133-138[Medline].
|
| 9.
|
Barthold, S. W., and L. K. Bockenstedt.
1993.
Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.
Infect. Immun.
61:4696-4702[Abstract/Free Full Text].
|
| 10.
|
Barthold, S. W., and M. de Souza.
1995.
Exacerbation of Lyme arthritis in beige mice.
J. Infect. Dis.
172:778-784[Medline].
|
| 11.
|
Barthold, S. W.,
D. H. Persing,
A. L. Armstrong, and R. A. Peeples.
1991.
Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.
Am. J. Pathol.
139:263-273[Abstract].
|
| 12.
|
Barthold, S. W.,
C. L. Sidman, and A. L. Smith.
1992.
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.
Am. J. Trop. Med. Hyg.
47:605-613.
|
| 13.
|
Boggemeyer, E.,
T. Stehle,
U. E. Schaible,
M. Hahne,
D. Vestweber, and M. M. Simon.
1994.
Borrelia burgdorferi upregulates the adhesion molecules E-selectin, P-selectin, ICAM-1 and VCAM-1 on mouse endothelioma cells in vitro.
Cell Adhesion Commun.
2:145-157[Medline].
|
| 14.
|
Burgdorfer, W.,
A. G. Barbour,
S. F. Hayes,
J. L. Benach,
E. Grunwaldt, and J. P. Davis.
1982.
Lyme disease: a tick-borne spirochetosis?
Science
216:1317-1319[Abstract/Free Full Text].
|
| 15.
|
Comstock, L. E., and D. D. Thomas.
1989.
Penetration of endothelial cell monolayers by Borrelia burgdorferi.
Infect. Immun.
57:1626-1628[Abstract/Free Full Text].
|
| 16.
|
Johnson, R. C.,
G. P. Schmid,
F. W. Hyde,
A. G. Steigwalt, and D. J. Brenner.
1984.
Borrelia burgdorferi sp. nov.: etiologic agent of Lyme disease.
Int. J. Syst. Bacteriol.
34:496-497.
|
| 17.
|
Keane-Myers, A., and S. P. Nickell.
1995.
Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.
J. Immunol.
155:2020-2028[Abstract].
|
| 18.
|
Lam, T. T.,
T. P. Nguyen,
E. Fikrig, and R. A. Flavell.
1994.
A chromosomal Borrelia burgdorferi gene encodes a 22-kilodalton lipoprotein, P22, that is serologically recognized in Lyme disease.
J. Clin. Microbiol.
32:876-883[Abstract/Free Full Text].
|
| 19.
|
Ma, Y.,
K. P. Seiler,
K. F. Tai,
L. Yang,
M. Woods, and J. J. Weis.
1994.
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway.
Infect. Immun.
62:3663-3671[Abstract/Free Full Text].
|
| 20.
|
Ma, Y., and J. J. Weis.
1993.
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.
Infect. Immun.
61:3843-3853[Abstract/Free Full Text].
|
| 21.
|
Matyniak, J. E., and S. L. Reiner.
1995.
T helper phenotype and genetic susceptibility in experimental Lyme disease.
J. Exp. Med.
181:1251-1254[Abstract/Free Full Text].
|
| 22.
|
Morrison, T. B.,
J. H. Weis, and J. J. Weis.
1997.
Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils.
J. Immunol.
158:4838-4845[Abstract].
|
| 23.
|
Nocton, J. J.,
F. Dressler,
B. J. Rutledge,
P. N. Rys,
D. H. Persing, and A. C. Steere.
1994.
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis.
N. Engl. J. Med.
330:229-234[Abstract/Free Full Text].
|
| 24.
|
Nocton, J. J., and A. C. Steere.
1995.
Lyme disease.
Adv. Intern.
40:69-117.
|
| 25.
|
Pachner, A. R.,
E. Delaney, and N. S. Ricalton.
1992.
Murine Lyme borreliosis: route of inoculation determines immune response and infectivity.
Reg. Immunol.
4:345-351[Medline].
|
| 26.
|
Pennington, P. M.,
C. D. Allred,
C. S. West,
R. Alvarez, and A. G. Barbour.
1997.
Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease.
Infect. Immun.
65:285-292[Abstract].
|
| 27.
|
Radolf, J. D.,
M. V. Norgard,
M. E. Brandt,
R. D. Isaacs,
P. A. Thompson, and B. Beutler.
1991.
Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct.
J. Immunol.
147:1968-1974[Abstract].
|
| 28.
|
Ramamoorthy, R.,
L. Povinelli, and M. T. Philipp.
1996.
Molecular characterization, genomic arrangement, and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi.
Infect. Immun.
64:1259-1264[Abstract].
|
| 29.
|
Ruderman, E. M.,
J. S. Kerr,
S. R. Telford III,
A. Spielman,
L. H. Glimcher, and E. M. Gravallese.
1995.
Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions.
J. Infect. Dis.
171:362-370[Medline].
|
| 30.
|
Schaible, U. E.,
R. Wallich,
M. D. Kramer,
G. Nerz,
T. Stehle,
C. Museteanu, and M. M. Simon.
1994.
Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone.
Int. Immunol.
6:671-681[Abstract/Free Full Text].
|
| 31.
|
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913[Abstract/Free Full Text].
|
| 32.
|
Seiler, K. P.,
Z. Vavrin,
E. Eichwald,
J. Hibbs, Jr., and J. J. Weis.
1995.
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.
Infect. Immun.
63:3886-3895[Abstract].
|
| 33.
|
Sellati, T. J.,
L. D. Abrescia,
J. D. Radolf, and M. B. Furie.
1996.
Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro.
Infect. Immun.
64:3180-3187[Abstract].
|
| 34.
|
Sellati, T. J.,
M. J. Burns,
M. A. Ficazzola, and M. B. Furie.
1995.
Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro.
Infect. Immun.
63:4439-4447[Abstract].
|
| 35.
|
Suk, K.,
S. Das,
W. Sun,
B. Jwang,
S. W. Barthold,
R. A. Flavell, and E. Fikrig.
1995.
Borrelia burgdorferi genes selectively expressed in the infected host.
Proc. Natl. Acad. Sci. USA
92:4269-4273[Abstract/Free Full Text].
|
| 36.
|
Szczepanski, A.,
M. B. Furie,
J. L. Benach,
B. P. Lane, and H. B. Fleit.
1990.
Interaction between Borrelia burgdorferi and endothelium in vitro.
J. Clin. Invest.
85:1637-1647.
|
| 37.
|
Tan, S. S., and J. H. Weis.
1992.
Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times.
PCR Appl. Methods
2:137-143.
|
| 38.
|
van Dam, A. P.,
H. Kuiper,
K. Vos,
A. Widjojokusumo,
B. M. de Jongh,
L. Spanjaard,
A. C. Ramselaar,
M. D. Kramer, and J. Dankert.
1993.
Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.
Clin. Infect. Dis.
17:708-717[Medline].
|
| 39.
|
Wallich, R.,
C. Brenner,
M. D. Kramer, and M. M. Simon.
1995.
Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.
Infect. Immun.
63:3327-3335[Abstract].
|
| 40.
|
Wooten, R. M.,
V. R. Modur,
T. M. McIntyre, and J. J. Weis.
1996.
Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor- B and inflammatory activation in human endothelial cells.
J. Immunol.
157:4584-4590[Abstract].
|
| 41.
|
Yang, L.,
Y. Ma,
R. Schoenfeld,
M. Griffiths,
E. Eichwald,
B. Araneo, and J. J. Weis.
1992.
Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.
Infect. Immun.
60:3033-3041[Abstract/Free Full Text].
|
| 42.
|
Yang, L.,
J. H. Weis,
E. Eichwald,
C. P. Kolbert,
D. H. Persing, and J. J. Weis.
1994.
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.
Infect. Immun.
62:492-500[Abstract/Free Full Text].
|
Infect Immun, January 1998, p. 161-168, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, G., Petzke, M. M., Iyer, R., Wu, H., Schwartz, I.
(2008). Pattern of Proinflammatory Cytokine Induction in RAW264.7 Mouse Macrophages Is Identical for Virulent and Attenuated Borrelia burgdorferi. J. Immunol.
180: 8306-8315
[Abstract]
[Full Text]
-
Iliopoulou, B. P., Alroy, J., Huber, B. T.
(2007). CD28 Deficiency Exacerbates Joint Inflammation upon Borrelia burgdorferi Infection, Resulting in the Development of Chronic Lyme Arthritis. J. Immunol.
179: 8076-8082
[Abstract]
[Full Text]
-
Jacobson, A. C., Ma, Y., Zachary, J. F., Weis, J. J., Weis, J. H.
(2007). Mice Lacking CD21 and CD35 Proteins Mount Effective Immune Responses against Borrelia burgdorferi Infection. Infect. Immun.
75: 2075-2078
[Abstract]
[Full Text]
-
Crandall, H., Dunn, D. M., Ma, Y., Wooten, R. M., Zachary, J. F., Weis, J. H., Weiss, R. B., Weis, J. J.
(2006). Gene Expression Profiling Reveals Unique Pathways Associated with Differential Severity of Lyme Arthritis. J. Immunol.
177: 7930-7942
[Abstract]
[Full Text]
-
Lazarus, J. J., Meadows, M. J., Lintner, R. E., Wooten, R. M.
(2006). IL-10 Deficiency Promotes Increased Borrelia burgdorferi Clearance Predominantly through Enhanced Innate Immune Responses. J. Immunol.
177: 7076-7085
[Abstract]
[Full Text]
-
GLICKSTEIN, L. J., COBURN, J. L.
(2006). ASSOCIATION OF MACROPHAGE INFLAMMATORY RESPONSE AND CELL DEATH AFTER IN VITRO BORRELIA BURGDORFERI INFECTION WITH ARTHRITIS RESISTANCE. Am J Trop Med Hyg
75: 964-967
[Abstract]
[Full Text]
-
Parveen, N., Cornell, K. A., Bono, J. L., Chamberland, C., Rosa, P., Leong, J. M.
(2006). Bgp, a Secreted Glycosaminoglycan-Binding Protein of Borrelia burgdorferi Strain N40, Displays Nucleosidase Activity and Is Not Essential for Infection of Immunodeficient Mice.. Infect. Immun.
74: 3016-3020
[Abstract]
[Full Text]
-
Crowley, H., Alroy, J., Sproule, T. J., Roopenian, D., Huber, B. T.
(2006). The MHC class I-related FcRn ameliorates murine Lyme arthritis. Int Immunol
18: 409-414
[Abstract]
[Full Text]
-
Crandall, H., Ma, Y., Dunn, D. M., Sundsbak, R. S., Zachary, J. F., Olofsson, P., Holmdahl, R., Weis, J. H., Weiss, R. B., Teuscher, C., Weis, J. J.
(2005). Bb2Bb3 Regulation of Murine Lyme Arthritis Is Distinct from Ncf1 and Independent of the Phagocyte Nicotinamide Adenine Dinucleotide Phosphate Oxidase. Am. J. Pathol.
167: 775-785
[Abstract]
[Full Text]
-
Guerau-de-Arellano, M., Alroy, J., Huber, B. T.
(2005). {beta}2 Integrins Control the Severity of Murine Lyme Carditis. Infect. Immun.
73: 3242-3250
[Abstract]
[Full Text]
-
Wang, X., Ma, Y., Weis, J. H., Zachary, J. F., Kirschning, C. J., Weis, J. J.
(2005). Relative Contributions of Innate and Acquired Host Responses to Bacterial Control and Arthritis Development in Lyme Disease. Infect. Immun.
73: 657-660
[Abstract]
[Full Text]
-
Wang, G., Iyer, R., Bittker, S., Cooper, D., Small, J., Wormser, G. P., Schwartz, I.
(2004). Variations in Barbour-Stoenner-Kelly Culture Medium Modulate Infectivity and Pathogenicity of Borrelia burgdorferi Clinical Isolates. Infect. Immun.
72: 6702-6706
[Abstract]
[Full Text]
-
Brown, C. R., Blaho, V. A., Loiacono, C. M.
(2004). Treatment of Mice with the Neutrophil-Depleting Antibody RB6-8C5 Results in Early Development of Experimental Lyme Arthritis via the Recruitment of Gr-1- Polymorphonuclear Leukocyte-Like Cells. Infect. Immun.
72: 4956-4965
[Abstract]
[Full Text]
-
Yang, X. F., Pal, U., Alani, S. M., Fikrig, E., Norgard, M. V.
(2004). Essential Role for OspA/B in the Life Cycle of the Lyme Disease Spirochete. J. Exp. Med.
199: 641-648
[Abstract]
[Full Text]
-
Munson, E. L., DeCoster, D. J., Nardelli, D. T., England, D. M., Callister, S. M., Schell, R. F.
(2004). Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice. CVI
11: 35-41
[Abstract]
[Full Text]
-
Wang, G., Liveris, D., Brei, B., Wu, H., Falco, R. C., Fish, D., Schwartz, I.
(2003). Real-Time PCR for Simultaneous Detection and Quantification of Borrelia burgdorferi in Field-Collected Ixodes scapularis Ticks from the Northeastern United States. Appl. Environ. Microbiol.
69: 4561-4565
[Abstract]
[Full Text]
-
Brown, C. R., Blaho, V. A., Loiacono, C. M.
(2003). Susceptibility to Experimental Lyme Arthritis Correlates with KC and Monocyte Chemoattractant Protein-1 Production in Joints and Requires Neutrophil Recruitment Via CXCR2. J. Immunol.
171: 893-901
[Abstract]
[Full Text]
-
Crother, T. R., Champion, C. I., Wu, X.-Y., Blanco, D. R., Miller, J. N., Lovett, M. A.
(2003). Antigenic Composition of Borrelia burgdorferi during Infection of SCID Mice. Infect. Immun.
71: 3419-3428
[Abstract]
[Full Text]
-
Giambartolomei, G. H., Dennis, V. A., Lasater, B. L., Murthy, P. K., Philipp, M. T.
(2002). Autocrine and Exocrine Regulation of Interleukin-10 Production in THP-1 Cells Stimulated with Borrelia burgdorferi Lipoproteins. Infect. Immun.
70: 1881-1888
[Abstract]
[Full Text]
-
Potter, M. R., Rittling, S. R., Denhardt, D. T., Roper, R. J., Weis, J. H., Teuscher, C., Weis, J. J.
(2002). Role of Osteopontin in Murine Lyme Arthritis and Host Defense against Borrelia burgdorferi. Infect. Immun.
70: 1372-1381
[Abstract]
[Full Text]
-
Wooten, R. M., Ma, Y., Yoder, R. A., Brown, J. P., Weis, J. H., Zachary, J. F., Kirschning, C. J., Weis, J. J.
(2002). Toll-Like Receptor 2 Is Required for Innate, But Not Acquired, Host Defense to Borrelia burgdorferi. J. Immunol.
168: 348-355
[Abstract]
[Full Text]
-
Wang, G., Ojaimi, C., Iyer, R., Saksenberg, V., McClain, S. A., Wormser, G. P., Schwartz, I.
(2001). Impact of Genotypic Variation of Borrelia burgdorferi Sensu Stricto on Kinetics of Dissemination and Severity of Disease in C3H/HeJ Mice. Infect. Immun.
69: 4303-4312
[Abstract]
[Full Text]
-
Thomas, V., Anguita, J., Barthold, S. W., Fikrig, E.
(2001). Coinfection with Borrelia burgdorferi and the Agent of Human Granulocytic Ehrlichiosis Alters Murine Immune Responses, Pathogen Burden, and Severity of Lyme Arthritis. Infect. Immun.
69: 3359-3371
[Abstract]
[Full Text]
-
Potter, M. R., Noben-Trauth, N., Weis, J. H., Teuscher, C., Weis, J. J.
(2000). Interleukin-4 (IL-4) and IL-13 Signaling Pathways Do Not Regulate Borrelia burgdorferi-Induced Arthritis in Mice: IgG1 Is Not Required for Host Control of Tissue Spirochetes. Infect. Immun.
68: 5603-5609
[Abstract]
[Full Text]
-
McKisic, M. D., Barthold, S. W.
(2000). T-Cell-Independent Responses to Borrelia burgdorferi Are Critical for Protective Immunity and Resolution of Lyme Disease. Infect. Immun.
68: 5190-5197
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(2000). Bone-Marrow Chimeras Reveal Hemopoietic and Nonhemopoietic Control of Resistance to Experimental Lyme Arthritis. J. Immunol.
165: 1446-1452
[Abstract]
[Full Text]
-
Shang, E. S., Champion, C. I., Wu, X.-Y., Skare, J. T., Blanco, D. R., Miller, J. N., Lovett, M. A.
(2000). Comparison of Protection in Rabbits against Host-Adapted and Cultivated Borrelia burgdorferi following Infection-Derived Immunity or Immunization with Outer Membrane Vesicles or Outer Surface Protein A. Infect. Immun.
68: 4189-4199
[Abstract]
[Full Text]
-
Anguita, J., Samanta, S., Revilla, B., Suk, K., Das, S., Barthold, S. W., Fikrig, E.
(2000). Borrelia burgdorferi Gene Expression In Vivo and Spirochete Pathogenicity. Infect. Immun.
68: 1222-1230
[Abstract]
[Full Text]
-
Brown, J. P., Zachary, J. F., Teuscher, C., Weis, J. J., Wooten, R. M.
(1999). Dual Role of Interleukin-10 in Murine Lyme Disease: Regulation of Arthritis Severity and Host Defense. Infect. Immun.
67: 5142-5150
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(1999). Experimental Lyme Arthritis in the Absence of Interleukin-4 or Gamma Interferon. Infect. Immun.
67: 3329-3333
[Abstract]
[Full Text]
-
Morrison, T. B., Ma, Y., Weis, J. H., Weis, J. J.
(1999). Rapid and Sensitive Quantification of Borrelia burgdorferi-Infected Mouse Tissues by Continuous Fluorescent Monitoring of PCR. J. Clin. Microbiol.
37: 987-992
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(1999). Genetic Control of Experimental Lyme Arthritis in the Absence of Specific Immunity. Infect. Immun.
67: 1967-1973
[Abstract]
[Full Text]
-
Weis, J. J., McCracken, B. A., Ma, Y., Fairbairn, D., Roper, R. J., Morrison, T. B., Weis, J. H., Zachary, J. F., Doerge, R. W., Teuscher, C.
(1999). Identification of Quantitative Trait Loci Governing Arthritis Severity and Humoral Responses in the Murine Model of Lyme Disease. J. Immunol.
162: 948-956
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(1998). Activation of Natural Killer Cells in Arthritis-Susceptible but Not Arthritis-Resistant Mouse Strains following Borrelia burgdorferi Infection. Infect. Immun.
66: 5208-5214
[Abstract]
[Full Text]
-
Cassatt, D. R., Patel, N. K., Ulbrandt, N. D., Hanson, M. S.
(1998). DbpA, but Not OspA, Is Expressed by Borrelia burgdorferi during Spirochetemia and Is a Target for Protective Antibodies. Infect. Immun.
66: 5379-5387
[Abstract]
[Full Text]
-
Seiler, K. P., Ma, Y., Weis, J. H., Frenette, P. S., Hynes, R. O., Wagner, D. D., Weis, J. J.
(1998). E and P Selectins Are Not Required for Resistance to Severe Murine Lyme Arthritis. Infect. Immun.
66: 4557-4559
[Abstract]
[Full Text]